Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

What'd You Call Me?

April 17th 2015, 10:24pm

Article

Terminal illness is like watching a bus barreling toward you and you're stuck in the road. The least you can do is make the wait enjoyable.

Comfort In God

April 9th 2015, 7:49pm

Article

Finding spiritual comfort in the midst of cancer, it can be done.

The Cancer-Life Balance: Or To Wear Cute Shoes Or Not Wear Cute Shoes

April 2nd 2015, 8:00pm

Article

The balance between living and living with cancer sometimes comes down to taking short medical breaks just to go on with your day.

Tykerb Falls Short Versus Herceptin, Adding Clarity to Frontline HER2-Positive Metastatic Breast Cancer Strategy

March 23rd 2015, 6:35pm

Article

First-line treatment with Tykerb and a taxane failed to improve progression-free survival versus Herceptin plus a taxane in patients with HER2-positive metastatic breast cancer.

Not My Time to Say Goodbye

March 23rd 2015, 5:04pm

Article

Saying goodbye to a friend in the middle of a shared cancer diagnosis can challenge the soul.

A Beautiful Life of Cancer Denial

March 5th 2015, 2:22am

Article

Living in denial is sometimes not such a bad idea, especially when it comes to cancer.

We Are The 30%

February 27th 2015, 1:32am

Article

Metastatic breast cancer will strike 30% of all breast cancer survivors yet only 2% of funds go to research this deadly cancer.

Clinical Implications of Ibrance's Approval for Metastatic Breast Cancer

February 12th 2015, 10:43pm

Article

Richard Finn, of the Jonsson Comprehensive Cancer Center at UCLA and lead investigator of the PALOMA-1 study, explains the clinical implications of Ibrance's approval for hormone-positive, HER2-negative metastatic breast cancer.

Ibrance Approved for Metastatic Breast Cancer

February 4th 2015, 7:17am

Article

The anticipated approval of Ibrance (palbociclib) came two months ahead of expectations, as the FDA granted an accelerated approval to the drug as a frontline treatment for women with ER-positive, HER2-negative metastatic breast cancer.

The BEST New Year's Eve

January 2nd 2015, 1:08am

Article

When was your last truly remarkable New Year's Eve?